These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 8211208)

  • 21. [T-cell-rich B-cell lymphoma. Presentation of 3 cases].
    Rodríguez JN; Borrero JJ; Fernández-Jurado A; Creagh R; Martino ML; Aguayo M; Prados D
    Sangre (Barc); 1997 Oct; 42(5):419-22. PubMed ID: 9424746
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Immunophenotyping in the differential diagnosis of malignant non-hodgkin's lymphomas].
    Dzembak TM; Gurkalo VK; Gershanovich ML
    Vopr Onkol; 1996; 42(5):63-6. PubMed ID: 9064906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro transformation of peripheral human lymphocytes by an autologous malignant DNA.
    Sen L; Suarez HG; De Salum SB; Pavlovsky S; Pavlovsky A; Bachmann AE
    Medicina (B Aires); 1972; 32(5):428-36. PubMed ID: 4678780
    [No Abstract]   [Full Text] [Related]  

  • 24. Flow cytometry of peripheral blood and bone marrow cells from patients with hairy cell leukemia: phenotype of hairy cells, lymphocyte subsets and detection of minimal residual disease after treatment.
    Babuŝíková O; Tomová A; Kusenda J; Gyárfás J
    Neoplasma; 2001; 48(5):350-7. PubMed ID: 11845978
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of adhesion molecules in chronic B-cell lymphoproliferative disorders.
    Lúcio PJ; Faria MT; Pinto AM; da Silva MR; Correia Júnior ME; da Costa RJ; Parreira AB
    Haematologica; 1998 Feb; 83(2):104-11. PubMed ID: 9549920
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prolymphocytic leukemia or prolymphocytic transformation of mantle cell lymphoma.
    Veillon DM; Nordberg ML; Glass J; Sattar T; Cotelingam JD
    Am J Clin Pathol; 2001 Nov; 116(5):781-2. PubMed ID: 11710698
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical utility of bone marrow flow cytometry in B-cell non-Hodgkin lymphomas (B-NHL).
    Perea G; Altés A; Bellido M; Aventín A; Bordes R; Ayats R; Remacha AF; Espinosa I; Briones J; Sierra J; Nomdedéu JF
    Histopathology; 2004 Sep; 45(3):268-74. PubMed ID: 15330805
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Idiopathic retroperitoneal fibrosis associated with immunohematological abnormalities.
    Oshiro H; Ebihara Y; Serizawa H; Shimizu T; Teshima S; Kuroda M; Kudo M
    Am J Med; 2005 Jul; 118(7):782-6. PubMed ID: 15989914
    [No Abstract]   [Full Text] [Related]  

  • 29. [The effect of lymphocyte homing receptors in the progression and prognosis of lymphoma].
    Joensuu H; Klemi P; Söderström KO; Jalkanen S
    Duodecim; 1992; 108(4):387-92. PubMed ID: 1366035
    [No Abstract]   [Full Text] [Related]  

  • 30. [Reticulosarcoma].
    Shtern RD
    Arkh Patol; 1970; 32(8):9-24. PubMed ID: 4920976
    [No Abstract]   [Full Text] [Related]  

  • 31. [Lymphoreticular reaction. New theory on the development of the lymphoblastomas (immunoblastomas)].
    Steigleder GK
    Z Hautkr; 1974 Dec; 49(23):987-95. PubMed ID: 4615451
    [No Abstract]   [Full Text] [Related]  

  • 32. MT2 immunoreactivity, cellular proliferation and prognosis in B-cell non-Hodgkin's lymphoma.
    Hall PA; Gregory WM; Stansfeld AG
    Histopathology; 1989 May; 14(5):523-5. PubMed ID: 2737621
    [No Abstract]   [Full Text] [Related]  

  • 33. Cell adhesion molecule expression and homing of hematologic malignancies.
    Timens W
    Crit Rev Oncol Hematol; 1995 Jun; 19(2):111-29. PubMed ID: 7612179
    [No Abstract]   [Full Text] [Related]  

  • 34. [Distribution of lymphocytes from normal cattle and cattle with different forms of lympholeukemia according to DNA content].
    Blazhko VV; Nikolaeva NV; Itkin BZ
    Izv Akad Nauk SSSR Biol; 1980; (4):625-31. PubMed ID: 6893336
    [No Abstract]   [Full Text] [Related]  

  • 35. Tumoral disease induced in hamsters by human leukemic material.
    Nastac E; Ionescu T; Athanasiu P; Demetrescu R; Velciu V; Ursea N
    Rev Roum Med Intern; 1973; 10(4):347-50. PubMed ID: 4582777
    [No Abstract]   [Full Text] [Related]  

  • 36. Prognostic factors in lymphomas: the contribution of immunophenotyping and molecular studies.
    Berger MS
    Curr Opin Immunol; 1989-1990; 2(5):719-22. PubMed ID: 2701973
    [No Abstract]   [Full Text] [Related]  

  • 37. [In vitro culture of cell line derived from a human lymphosarcoma. I. Cytochemistry, cytogenetics and ultrastructure].
    Suárez HG; Brieux de Salum S; Pavlovsky S; Ruibal B; Pavlovsky A
    Int J Cancer; 1969 Nov; 4(6):880-90. PubMed ID: 5395928
    [No Abstract]   [Full Text] [Related]  

  • 38. Magnetic resonance spectroscopy and clinical cancer prognosis.
    Zakian KL; Koutcher JA
    Acad Radiol; 2004 Apr; 11(4):365-7. PubMed ID: 15109008
    [No Abstract]   [Full Text] [Related]  

  • 39. Targeting Immune Checkpoints in Hematologic Malignancies.
    Alatrash G; Daver N; Mittendorf EA
    Pharmacol Rev; 2016 Oct; 68(4):1014-1025. PubMed ID: 27664133
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunobiologic correlates of prognosis in lymphoma.
    Grogan TM; Miller TP
    Semin Oncol; 1993 Oct; 20(5 Suppl 5):58-74. PubMed ID: 8211208
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.